- Home
- STTK vs KLTR Comparison
STTK vs KLTR Comparison
Compare STTK & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- KLTR
- Stock Information
- Founded
- STTK 2016
- KLTR 2006
- Country
- STTK United States
- KLTR United States
- Employees
- STTK N/A
- KLTR N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- KLTR EDP Services
- Sector
- STTK Health Care
- KLTR Technology
- Exchange
- STTK Nasdaq
- KLTR Nasdaq
- Market Cap
- STTK 173.6M
- KLTR 177.3M
- IPO Year
- STTK 2020
- KLTR 2021
- Fundamental
- Price
- STTK $3.73
- KLTR $1.24
- Analyst Decision
- STTK Strong Buy
- KLTR Buy
- Analyst Count
- STTK 3
- KLTR 3
- Target Price
- STTK $10.67
- KLTR $2.67
- AVG Volume (30 Days)
- STTK 152.2K
- KLTR 99.8K
- Earning Date
- STTK 11-07-2024
- KLTR 08-08-2024
- Dividend Yield
- STTK N/A
- KLTR N/A
- EPS Growth
- STTK N/A
- KLTR N/A
- EPS
- STTK N/A
- KLTR N/A
- Revenue
- STTK $4,123,999.00
- KLTR $176,832,000.00
- Revenue This Year
- STTK $164.45
- KLTR $2.29
- Revenue Next Year
- STTK N/A
- KLTR $2.32
- P/E Ratio
- STTK N/A
- KLTR N/A
- Revenue Growth
- STTK 380.09
- KLTR 2.65
- 52 Week Low
- STTK $1.33
- KLTR $0.76
- 52 Week High
- STTK $11.76
- KLTR $2.03
- Technical
- Relative Strength Index (RSI)
- STTK 53.19
- KLTR 52.44
- Support Level
- STTK $3.37
- KLTR $1.18
- Resistance Level
- STTK $3.94
- KLTR $1.39
- Average True Range (ATR)
- STTK 0.23
- KLTR 0.09
- MACD
- STTK 0.08
- KLTR -0.00
- Stochastic Oscillator
- STTK 70.00
- KLTR 53.85
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.